Abstract
Background: Colon cancer remains among the top perpetrators of deaths linked to cancer. The probability of cancer reaching more parts of the body is extremely high in colorectal cancers. Early detection is hence, highly important for faster treatment.
Method: In the current work, a hybrid approach toward the detection of colon cancers through the usage of microarray datasets, is presented. Particle Swarm Optimization (PSO) is utilized for features extraction, while Support Vector Machine (SVM) and Bagging approaches are utilized as classifiers.
Results: The Colon Microarray Gene Dataset is used to evaluate minimum Redundancy Maximum Relevance (mRMR), Bagging, SVM, PSO and PSO-SVM with regard to classification accuracy, sensitivity and specificity. The proposed PSO-SVM displays best performance in all categories.
Conclusion: Experiments reveal the capabilities of the proposed PSO-SVM to explore features space for the optimal features combination for gene selection from microarray data.
Keywords: Colon cancer, microarray data, Support Vector Machine (SVM), Particle Swarm Optimization (PSO), Bagging, minimum Redundancy Maximum Relevancy (mRMR), beam search.
Graphical Abstract
Current Signal Transduction Therapy
Title:Hybrid Soft Computing Approach for Prediction of Cancer in Colon Using Microarray Gene Data
Volume: 11 Issue: 2
Author(s): Krishnaraj Nagappan, Ezhilarasu Palani and Xiao-Zhi Gao
Affiliation:
Keywords: Colon cancer, microarray data, Support Vector Machine (SVM), Particle Swarm Optimization (PSO), Bagging, minimum Redundancy Maximum Relevancy (mRMR), beam search.
Abstract: Background: Colon cancer remains among the top perpetrators of deaths linked to cancer. The probability of cancer reaching more parts of the body is extremely high in colorectal cancers. Early detection is hence, highly important for faster treatment.
Method: In the current work, a hybrid approach toward the detection of colon cancers through the usage of microarray datasets, is presented. Particle Swarm Optimization (PSO) is utilized for features extraction, while Support Vector Machine (SVM) and Bagging approaches are utilized as classifiers.
Results: The Colon Microarray Gene Dataset is used to evaluate minimum Redundancy Maximum Relevance (mRMR), Bagging, SVM, PSO and PSO-SVM with regard to classification accuracy, sensitivity and specificity. The proposed PSO-SVM displays best performance in all categories.
Conclusion: Experiments reveal the capabilities of the proposed PSO-SVM to explore features space for the optimal features combination for gene selection from microarray data.
Export Options
About this article
Cite this article as:
Nagappan Krishnaraj, Palani Ezhilarasu and Gao Xiao-Zhi, Hybrid Soft Computing Approach for Prediction of Cancer in Colon Using Microarray Gene Data, Current Signal Transduction Therapy 2016; 11 (2) . https://dx.doi.org/10.2174/1574362411666160616091549
DOI https://dx.doi.org/10.2174/1574362411666160616091549 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protein Kinase B/AKT and Focal Adhesion Kinase: Two Close Signaling Partners in Cancer
Anti-Cancer Agents in Medicinal Chemistry Membrane Transporters as Determinants of the Pharmacology of Platinum Anticancer Drugs
Current Cancer Drug Targets Synthesis, Biological Evaluation and Molecular Dynamics Simulation Studies of Novel Diphenyl Ethers
Medicinal Chemistry Resistance to Peloruside A and Laulimalide: Functional Significance of Acquired βI-tubulin Mutations at Sites Important for Drug-Tubulin Binding
Current Cancer Drug Targets Too Much of a Good Thing: Suicide Prevention Promotes Chemoresistance in Ovarian Carcinoma
Current Cancer Drug Targets Polo-Like Kinase 1 as a Potential Therapeutic Target for Osteosarcoma
Current Pharmaceutical Design Ruthenium Complexes as Anticancer Agents
Current Medicinal Chemistry The Design of Amphiphilic Polymeric Micelles of Curcumin for Cancer Management
Current Medicinal Chemistry Targeting Vascular Endothelial Growth Factor Pathway in First-Line Treatment of Metastatic Colorectal Cancer: State-of-the-Art and Future Perspectives in Clinical and Molecular Selection of Patients
Current Cancer Drug Targets Chitosan Nanoparticles: An Approbative System for the Delivery of Herbal Bioactives
The Natural Products Journal Metagenome Assembly Validation: Which Metagenome Contigs are Bona Fide?
Current Bioinformatics Issues in the Psychiatric Screening of Cancer Patients
Current Psychiatry Reviews Chemotherapy in Addition to Preoperative Radiotherapy in Locally Advanced Rectal Cancer – A Systematic Overview
Reviews on Recent Clinical Trials Corneal Neovascularization: Molecular Events and Therapeutic Options
Recent Patents on Inflammation & Allergy Drug Discovery Regulatory Role of the α7nAChR in Cancer
Current Drug Targets Natural Carriers for siRNA Delivery
Current Pharmaceutical Design Heme Oxygenase-1 in Tumor Biology and Therapy
Current Drug Targets Potential Association Between TLR4 and Chitinase 3-Like 1 (CHI3L1/YKL-40) Signaling on Colonic Epithelial Cells in Inflammatory Bowel Disease and Colitis-Associated Cancer
Current Molecular Medicine Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas
Current Cancer Drug Targets Selenium in the Prevention and Treatment of Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry